The role of the patient and family in infection prevention  by Duse, A.
38 16th ICID Abstracts / International Journal of Infectious Diseases 21S (2014) 1–460
Type: Invited Presentation
Final Abstract Number: 16.003
Session: Challenges and Controversies in Infection Prevention
Date: Friday, April 4, 2014
Time: 10:15-12:15
Room: Auditorium 2
Understanding and controlling an MRSA
outbreak using whole genome sequencing
S. Harris
Wellcome Trust Sanger Institute, Cambridge, United
Kingdom
The emergence of meticillin-resistant Staphylococcus aureus
(MRSA) that can persist in the community and replace existing
hospital-adapted lineages of MRSA means that it is necessary to
understand transmission dynamics within and between hospitals
and the community.WestudiedaputativeMRSAoutbreakona spe-
cial care baby unit (SCBU) at Addenbrooke’s Hospital, Cambridge,
UK. We used whole-genome sequencing to assess and improve-
upon the ﬁndings of an infection-control team who evaluated the
outbreak with conventional epidemiological analysis and antibi-
ogram proﬁles. We sequenced isolates from all colonised infants
on the SCBU, and from patients in the hospital or community who
had presented with MRSA with the same antibiotic susceptibility
proﬁle as the outbreak strain. The original infection control team
identiﬁed 12 cases of MRSA infection in infants over a 12-month
periodwhichwere suspected of being linked.However, a persistant
outbreak could not be conﬁrmed. Usingwhole-genome sequencing
we identiﬁed 26 related cases of MRSA carriage and showed trans-
mission occurredwithin the SCBU, betweenmothers on a postnatal
ward, and in the community. Basedonour results,wealsoproposed
that MRSA carriage by a staff member had allowed the outbreak to
persist during a period without known infection on the SCBU and
after a deep clean. Staff screening led to identiﬁcation anddecoloni-
sation of a staff carrier, which brought the outbreak on the ward to
a close. Whole-genome sequencing holds great promise for rapid,
accurate, and comprehensive identiﬁcation of bacterial transmis-
sion pathways both within hospitals and in the community, and
its widespread use in the clinical setting will bring reductions in
infections, morbidity, and costs.
http://dx.doi.org/10.1016/j.ijid.2014.03.493
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The role of the patient and family in infection
prevention
A. Duse
National Health Laboratory Service, Johannesburg,
South Africa
Infectious diseases remain a signiﬁcant cause of morbidity and
mortality worldwide accounting for more than 13 million deaths
annually. Infection prevention and control (IPC) as a discipline
historically tended to focus primarily on the role of healthcare pro-
fessionals in thepreventionof healthcare-associated (’nosocomial’)
infections. In 1997 the International Scientiﬁc Forum on Home
Hygiene (IFH) was formed with the mission to promote infection
prevention and control in the home setting and everyday life. Apart
from raising awareness of the important role of home hygiene in
preventing infectious diseases, the IFH has additionally aimed to
develop and promote hygiene and hygiene practices using sound
scientiﬁc principles. The IFH was, in many respects, an early pio-
neer in the recognition of the crucial role played by individuals
and their families in taking responsibility both independently and
togetherwith healthcare practitioners for infection prevention and
control (IPC) issues and personal health. More recently the role of
the patient and the family in IPC has been increasingly highlighted
bymany organizationsworldwide. IPC educationalmaterials, cam-
paigns and programs aimed at educating and empowering patients
and their families (one example is APIC’s ‘Infection Prevention and
YOU’ program aimed at “Spreading Knowledge. Preventing Infec-
tion”) arenoweasily available on theweb. This talkwill focus on the
roles of, and challenges experienced, by patients and their families
in safeguarding their health.
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Tracking resistance to antifungal drugs for
Candida spp
J. Coetzee
Johannesburg, South Africa
Fungal susceptibility testing has been coming of age in recent
years. Advances have included the establishment of species spe-
ciﬁc break point for different classes of antifungal agents, as well
as developments regarding the molecular detection of resistance
mutations. Experts previously believed the accurate speciation of
Candida isolates to be the most important determinant guiding
empirical choice of all antifungal agents. While this may still hold
true, resistance to antifungals have been emergingworldwide. This
is due to various factors, including the prophylactic use of antifun-
gal agents, the observation that under dosing of e.g. azoles such as
voriconazole can result in acquired resistance, and the increased
use of antifungals. The role of environmental factors in driving
resistance should also not be underestimated, as illustrated in the
recent discovery of azole resistant Aspergillus caused by the use
of azole based fungicides in agriculture. In comparing resistance
data from different regions in the world, it is important to note
both the date of the susceptibility testing as well as the interpre-
tive criteria use. Differences exist between the CLSI and EUCAST
breakpoints, and clinicians should be aware that the CLSI published
new break points in January 2013. These new break points have
had a signiﬁcant effect on the interpretive categorisation of cer-
tain drugs – e.g. lowering of voriconazole breakpoints for Candida
species. The methodology that was used to conduct the survey
should also be carefully noted, as the use of some of the com-
mercial antifungal susceptibility testing systemsmay be associated
